Bread Financial (NYSE:BFH) Given New $58.00 Price Target at The Goldman Sachs Group
Bread Financial (NYSE:BFH – Free Report) had its target price boosted by The Goldman Sachs Group from $52.00 to $58.00 in a research note published on Tuesday morning,Benzinga reports. They currently have a sell rating on the stock. Several other equities analysts have also recently issued reports on the stock. JPMorgan Chase & Co. boosted […]
The Goldman Sachs Group Raises Rocket Lab USA (NASDAQ:RKLB) Price Target to $12.00
Rocket Lab USA (NASDAQ:RKLB – Get Free Report) had its price objective lifted by analysts at The Goldman Sachs Group from $5.00 to $12.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the rocket manufacturer’s stock. The Goldman Sachs Group’s price target points to a […]
Topgolf Callaway Brands (NYSE:MODG) Price Target Lowered to $12.00 at The Goldman Sachs Group
Topgolf Callaway Brands (NYSE:MODG – Free Report) had its price target cut by The Goldman Sachs Group from $14.00 to $12.00 in a report published on Thursday,Benzinga reports. They currently have a neutral rating on the stock. A number of other research firms have also recently commented on MODG. Truist Financial lowered their price target […]
Braze (NASDAQ:BRZE) Price Target Lowered to $47.00 at The Goldman Sachs Group
Braze (NASDAQ:BRZE – Get Free Report) had its price target dropped by equities researchers at The Goldman Sachs Group from $65.00 to $47.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. The Goldman Sachs Group’s price objective points to a potential upside of […]
uniQure (NASDAQ:QURE) Given New $9.00 Price Target at The Goldman Sachs Group
uniQure (NASDAQ:QURE – Free Report) had its price objective lowered by The Goldman Sachs Group from $10.00 to $9.00 in a report released on Wednesday morning,Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the biotechnology company’s stock. A number of other equities research analysts also recently commented on the company. Raymond […]
Exact Sciences (NASDAQ:EXAS) Given New $65.00 Price Target at The Goldman Sachs Group
Exact Sciences (NASDAQ:EXAS – Free Report) had its price objective cut by The Goldman Sachs Group from $75.00 to $65.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the medical research company’s stock. Other analysts also recently issued research reports about the stock. Stifel Nicolaus reduced their price objective […]
last updated on 20 Nov 12:27